or Try an Advanced Search...

    Technical Analysis for HCWB - HCW Biologics Inc.

    Grade Last Price % Change Price Change
    F 0.43 -0.23% 0.00
    HCWB closed down 0.23 percent on Friday, November 1, 2024, on 12 percent of normal volume. It ran into resistance at its 50 day moving average. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical HCWB trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    50 DMA Resistance Bearish 0.00%
    Shooting Star Candlestick Bearish 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Narrow Range Bar Range Contraction -0.23%
    Wide Bands Range Expansion -0.23%
    Oversold Stochastic Weakness -0.23%
    Outside Day Range Expansion -4.23%
    Wide Bands Range Expansion -4.23%
    Older End-of-Day Signals for HCWB ...

       Recent Intraday Alerts

    Alert Time
    Reversed from Up about 18 hours ago
    60 Minute Opening Range Breakdown about 21 hours ago
    10 DMA Resistance about 21 hours ago
    Up 5% about 21 hours ago
    Up 10% about 21 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    HCWB Chart by TradingView
    Basic chart:

    Profile

    HCW Biologics Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation and age-related diseases. The company is involved in developing HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. It is also developing HCW9218 as an injectable immunotherapeutic for patients with pancreatic, breast, ovarian, colorectal, and prostate cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata. The company was incorporated in 2018 and is headquartered in Miramar, Florida.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Clinical Medicine Acute Myeloid Leukemia Immunotherapies Prostate Cancer Leukemia Oncogenes Pulmonary Fibrosis Treatment Of Acute Myeloid Leukemia Alopecia Areata

    Is HCWB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Aug 23 HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction
    Aug 16 Bullish HCW Biologics Insider Buying Worth US$2.57m Yet To Pay Off
    Aug 15 HCW Biologics reports Q2 results
    Aug 14 HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights
    May 15 HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights
    See more HCWB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.93
    52 Week Low 0.4
    Average Volume 28,231
    200-Day Moving Average 0.97
    50-Day Moving Average 0.52
    20-Day Moving Average 0.50
    10-Day Moving Average 0.48
    Average True Range 0.07
    RSI (14) 39.76
    ADX 21.05
    +DI 32.72
    -DI 16.16
    Chandelier Exit (Long, 3 ATRs) 0.45
    Chandelier Exit (Short, 3 ATRs) 0.61
    Upper Bollinger Bands 0.61
    Lower Bollinger Band 0.40
    Percent B (%b) 0.15
    BandWidth 41.47
    MACD Line -0.02
    MACD Signal Line -0.01
    MACD Histogram -0.0102
    Fundamentals Value
    Market Cap 15.47 Million
    Num Shares 36 Million
    EPS -0.56
    Price-to-Earnings (P/E) Ratio -0.77
    Price-to-Sales 14.85
    Price-to-Book 1.69
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.58
    Resistance 3 (R3) 0.59 0.56 0.55
    Resistance 2 (R2) 0.56 0.52 0.55 0.54
    Resistance 1 (R1) 0.50 0.50 0.48 0.48 0.54
    Pivot Point 0.46 0.46 0.45 0.45 0.46
    Support 1 (S1) 0.40 0.43 0.38 0.38 0.32
    Support 2 (S2) 0.36 0.40 0.36 0.32
    Support 3 (S3) 0.30 0.36 0.31
    Support 4 (S4) 0.28